From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 10, p. 8, doi. 10.1002/pu
- Publication type:
- Article
Works matching IS 10685308 AND DT 2015 AND VI 26 AND IP 10
Results: 7
1
2
High-quality evidence lacking for cannabinoids in medical treatment.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 10, p. 1, doi. 10.1002/pu.30081
- Publication type:
- Article
3
Antipsychotics for children decline, but concerns over prescribing remain.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 10, p. 4, doi. 10.1002/pu.30085
- Publication type:
- Article
4
Injectable risperidone shows effectiveness in first-episode schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 10, p. 3, doi. 10.1002/pu.30084
- Publication type:
- Article
5
Serotonin syndrome associated with morphine-phenelzine interaction.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
6
Adjunctive ziprasidone improves response in escitalopram-resistant depression.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 10, p. 1, doi. 10.1002/pu.30082
- Publication type:
- Article
7
RESEARCH ROUNDUP.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 10, p. 7, doi. 10.1002/pu.30086
- Publication type:
- Article